CAS: 96402-49-2; Fmoc-1-Nal-Oh

该化合物是一种受保护的氨基酸衍生物,广泛用于固相聚丙酸盐合成(SPPS),Fmoc (9-氟烯基甲基碳基)组是一个防雷组,能够在温和基本条件下有选择地进行保护,1-纳phthylaline的侧链引入芳香和疏水特性,因此对改变诸如捆绑的亲和稳定性等peptide特性很有价值.该化合物由于符合标准SPPS议定书,在设计基于peptide的治疗和生物化学探测器方面特别有用.高纯度和一贯性能确保可靠地纳入peptide序列,支持药物开发和结构研究.建议在水条件下进行适当处理以保持稳定性.

结构式图片

相似化合物

138774-93-3 55447-00-2 55516-54-6

欧盟法规

C&L通报

上下游产品

CAS号28920-43-6 芴甲氧羰酰氯(Fm°C-Cl) | CAS号55516-54-6 3-(1-萘基)-L-丙氨酸

合成工艺路线路线简述

    氯甲酸-9-芴基甲酯,3-(1-萘基)-L-丙氨酸置于sodium Carbonate体系中,化学反应生成 Fmoc-3-(1-萘基)-L-丙氨酸
    参考文献:Cyclic Peptides As Selective Tachykinin Antagonists
    标题:Cyclic Peptides As Selective Tachykinin Antagonists
    摘要:Twenty Homodetic Cyclic Peptides Based On The C-Terminal Sequence Of Substance P Were Prepared (Table I) By A Combination Of Solid-Phase Techniques And Cyclizations Using Azide Coupling Incorporation Of Dipeptide Mimics Based On Substituted Gamma-Lactams Were Used In Some Cases To Restrict Their Conformational Mobility. Five Of These Cyclic Peptides Were Shown To Have High Tachykinin Antagonist Activity (Pa2 > 6) At Nk-2 Receptors (Rat Vas Deferens). The Two Most Potent Of This Series,Xvii,Cyclo(Gln-Trp-Phe-Gly-Leu-Met) (Pa2 = 8.1),And I Cyclo(Gln-Trp-Phe-(R)Gly[anc-2]Leu-Met) (Pa2 = 6.7),Were Selective For Nk-2 Receptors Compared With The Other Tachykinin Receptors (Table Ii).
    DOI:10.1021/jm00053A001

    海关参考信息

    专利信息


    专利号:US-8598089-B2
    优先权日:2003-12-17
    标题 :Methods for synthesis of encoded libraries
    发明人:MORGAN BARRY; HALE STEPHEN; ARICO-MUENDEL CHRISTOPHER C; CLARK MATTHEW; WAGNER RICHARD; ISRAEL DAVID I; GEFTER MALCOLM L; BENJAMIN DENNIS; HANSEN NILS JAKOB VEST; KAVARANA MALCOLM J; CREASER STEFFAN PHILLIP; FRANKLIN GEORGE J; CENTRELLA PAOLO A; ACHARYA RAKSHA A
    权利人:MORGAN BARRY; HALE STEPHEN; ARICO-MUENDEL CHRISTOPHER C; CLARK MATTHEW; WAGNER RICHARD; ISRAEL DAVID I; GEFTER MALCOLM L; BENJAMIN DENNIS; HANSEN NILS JAKOB VEST; KAVARANA MALCOLM J; CREASER STEFFAN PHILLIP; FRANKLIN GEORGE J; CENTRELLA PAOLO A; ACHARYA RAKSHA A; GLAXOSMITHKLINE LLC
    摘要:The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.

    专利号:US-8410028-B2
    优先权日:2003-12-17
    标 题:Methods for synthesis of encoded libraries
    发明人:MORGAN BARRY; HALE STEPHEN; ARICO-MUENDEL CHRISTOPHER C; CLARK MATTHEW; WAGNER RICHARD; ISRAEL DAVID I; GEFTER MALCOLM L; BENJAMIN DENNIS; HANSEN NILS JAKOB VEST; KAVARANA MALCOLM J; CREASER STEFFAN PHILLIP; FRANKLIN GEORGE J; CENTRELLA PAOLO A; ACHARYA RAKSHA A
    权利人:MORGAN BARRY; HALE STEPHEN; ARICO-MUENDEL CHRISTOPHER C; CLARK MATTHEW; WAGNER RICHARD; ISRAEL DAVID I; GEFTER MALCOLM L; BENJAMIN DENNIS; HANSEN NILS JAKOB VEST; KAVARANA MALCOLM J; CREASER STEFFAN PHILLIP; FRANKLIN GEORGE J; CENTRELLA PAOLO A; ACHARYA RAKSHA A; GLAXOSMITHKLINE LLC
    摘要:The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.

    专利号:US-8933195-B2
    优先权日:2011-11-17
    标题:Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments
    发明人:JIANG SHENG; LI SHANG; YAO ZHIYI; YAO YIWU; ZHANG FENG; CHAO YANG; YE HAI; CHEN MIN
    权利人:JIANG SHENG; LI SHANG; YAO ZHIYI; YAO YIWU; ZHANG FENG; CHAO YANG; YE HAI; CHEN MIN; NANJING YOKO BIOMEDICAL R & D LTD; NANJING XINGANG MEDICAL CO LTD; NANJING YOKO PHARMACEUTICAL CO LTD
    摘要:The invention provides histone deacetylase (HDAC) inhibitors shown as Formula I, where R 1 to R 8 are as defined in the specification. The invention also provides methods for synthesis of these compounds and applications of these compounds in preparing pharmaceuticals for preventing or treating mammal diseases related to the dysregulation of HDAC.

    专利号:US-2007042401-A1
    优先权日:2003-12-17
    标题 :Methods for synthesis of encoded libraries

    专利号:EP-3515880-B1
    优先权日:2017-03-17
    标题:Methods and compositions for synthesis of encoded libraries
    发明人:LI JIN; MORGAN BARRY A; Wan jinqiao; DOU DENGFENG; LIU GUANSAI; CHANG YONG; CHEN QIUXIA; WANG XING; XU YANSHAN; HU DONGYAN; LIU JIAN; CHENG XUEMIN
    权利人:HITGEN INC

    专利号:US-2020149034-A1
    优先权日:2017-03-17
    标题:Methods and Compositions for Synthesis of Encoded Libraries
    南京肽业生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.njpeptide.com
    电话: 025-5836-1106 18061682050👤
    📞南京肽业生物科技有限公司 ⚠️参考联系方式

    销售电话:025-5836-1106 18061682050
    邮箱:Jun.qian@njpeptide.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海正极生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bioplus.com.cn
    电话: 021-64847500👤
    📞上海正极生物科技有限公司 ⚠️参考联系方式

    销售电话:021-64847500
    邮箱:sales@bioplus.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海瀛正科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.intechem.com
    电话: 021-51560106👤
    📞上海瀛正科技有限公司 ⚠️参考联系方式

    销售电话:021-51560106
    邮箱:wj18918939007@yahoo.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Synthesis And Biological Activity Of Peptide α-Ketoamide Derivatives As Proteasome Inhibitors
    作者:Salvatore Pacifico,Valeria Ferretti,Valentina Albanese,Anna Fantinati,Eleonora Gallerani,Francesco Nicoli,Riccardo Gavioli,Francesco Zamberlan,Delia Preti,Mauro Marastoni |发布日期:2019.7.11
    摘要:Proteasome Activity Affects Cell Cycle Progression As Well As The Immune Response, And It Is Largely Recognized As An Attractive Pharmacological Target For Potential Therapies Against Several Diseases. Herein We Present The Synthesis Of A Series Of Pseudodi/tripeptides Bearing At The C-Terminal Position Different α-Ketoamide Moieties As Pharmacophoric Units For The Interaction With The Catalytic Threonine

    合成参考文献


    参考文献:10.1007/s10534-013-9638-y
    摘要:Morris G, Robertson I, Tatko CD. Iron binding β-hairpin peptides. Biometals. 2013 Oct;26(5):667–75. doi: 10.1007/s10534-013-9638-y.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知